Premium
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient
Author(s) -
Tong S.Y.C.,
Peleg A.Y.,
Yoong J.,
Handke R.,
Szer J.,
Slavin M.
Publication year - 2007
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/j.1399-3062.2007.00203.x
Subject(s) - voriconazole , medicine , terbinafine , regimen , amphotericin b , intensive care medicine , surgery , antifungal , dermatology , itraconazole
Breakthrough invasive fungal infections among patients with hematologic malignancies receiving voriconazole are being reported with increasing frequency, with zygomycete infections predominating. We report a case of disseminated Scedosporium prolificans infection in a patient receiving voriconazole prophylaxis. Despite poor in vitro activity of voriconazole for this organism, synergy studies using the checkerboard method demonstrated synergy with the combination of voriconazole and terbinafine. This regimen, in conjunction with central venous line removal and intravitreal voriconazole, contributed to the recovery of the patient. S. prolificans is a life‐threatening mold that should be considered in patients with breakthrough invasive fungal infections while on voriconazole prophylaxis.